Skip to content

Author

Xuejun Shi

We have 1 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

CTPS1 promotes lung adenocarcinoma progression as a targetable vulnerability.

Targeting CTPS1 with STP938, alone or in combination with osimertinib, represents a promising therapeutic strategy and supports CTPS1 as a targetable vulnerability in lung adenocarcinoma.

Hui Xie, Cai-Xia Xu, Bing-Han Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.